CA-82739/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2001	1
2004	1
2005	1
2025	0

Page 1

Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo.

Savorè C, Zhang C, Muir C, Liu R, Wyrwa J, Shu J, Zhau HE, Chung LW, Carson DD, Farach-Carson MC. Savorè C, et al. Clin Exp Metastasis. 2005;22(5):377-90. doi: 10.1007/s10585-005-2339-3. Clin Exp Metastasis. 2005. PMID: 16283481

Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line.

Cinar B, Koeneman KS, Edlund M, Prins GS, Zhau HE, Chung LW. Cinar B, et al. Cancer Res. 2001 Oct 1;61(19):7310-7. Cancer Res. 2001. PMID: 11585771

Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.

Cinar B, Yeung F, Konaka H, Mayo MW, Freeman MR, Zhau HE, Chung LW. Cinar B, et al. Biochem J. 2004 Apr 15;379(Pt 2):421-31. doi: 10.1042/BJ20031661. Biochem J. 2004. PMID: 14715080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year